Abstract | BACKGROUND: With the dissemination of carbapenemase producers, a revival of colistin was observed for the treatment of infections caused by MDR Gram-negatives. Unfortunately, the increasing usage of colistin led to the emergence of resistance. In Klebsiella pneumoniae, colistin resistance arises through addition of 4-amino-l-arabinose (l-Ara4N) or phosphoethanolamine (pEtN) to the native lipid A. The underlying mechanisms involve numerous chromosome-encoded genes or the plasmid-encoded pEtN transferase MCR. Currently, detection of colistin resistance is time-consuming since it still relies on MIC determination by broth microdilution. Recently, a rapid diagnostic test based on MALDI-TOF MS detection of modified lipid A was developed (the MALDIxin test) and tested on Escherichia coli and Acinetobacter baumannii. OBJECTIVES: Optimize the MALDIxin test for the rapid detection of colistin resistance in K. pneumoniae. METHODS: This optimization consists of an additional mild- acid hydrolysis of 15 min in 1% acetic acid. The optimized method was tested on a collection of 81 clinical K. pneumoniae isolates, including 49 colistin-resistant isolates (45 with chromosome-encoded resistance, 3 with MCR-related resistance and 1 with both mechanisms). RESULTS: The optimized method allowed the rapid (<30 min) identification of l-Ara4N- and pEtN-modified lipid A of K. pneumoniae, which are known to be the real triggers of polymyxin resistance. At the same time, it discriminates between chromosome-encoded and MCR-related polymyxin resistance. CONCLUSIONS: The MALDIxin test has the potential to become an accurate tool for the rapid determination of colistin resistance in clinically relevant Gram-negative bacteria.
|
Authors | Laurent Dortet, Agnieszka Broda, Sandrine Bernabeu, Youri Glupczynski, Pierre Bogaerts, Rémy Bonnin, Thierry Naas, Alain Filloux, Gerald Larrouy-Maumus |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 75
Issue 1
Pg. 110-116
(01 01 2020)
ISSN: 1460-2091 [Electronic] England |
PMID | 31580426
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. |
Chemical References |
- Anti-Bacterial Agents
- Lipid A
- Colistin
|
Topics |
- Anti-Bacterial Agents
(pharmacology)
- Colistin
(pharmacology)
- Drug Resistance, Bacterial
- Humans
- Klebsiella pneumoniae
(drug effects)
- Lipid A
(chemistry)
- Microbial Sensitivity Tests
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
|